BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1328078)

  • 41. Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women.
    Syrjänen KJ; Mäntyjärvi R; Väyrynen M; Yliskoski M; Syrjänen SM; Saarikoski S; Nurmi T; Parkkinen S; Castrén O
    Acta Cytol; 1987; 31(6):855-65. PubMed ID: 2827414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus in women. A three-year experience in a county hospital colposcopy clinic.
    Cartwright PS; Dao AH; Reed GW
    J Reprod Med; 1992 Feb; 37(2):167-9. PubMed ID: 1311381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colposcopy is superior to cytology for the detection of early genital human papillomavirus infection.
    Schneider A; Sterzik K; Buck G; De Villiers EM
    Obstet Gynecol; 1988 Feb; 71(2):236-41. PubMed ID: 2827083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus.
    Feingold AR; Vermund SH; Burk RD; Kelley KF; Schrager LK; Schreiber K; Munk G; Friedland GH; Klein RS
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):896-903. PubMed ID: 2166784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytologic correlates of cervical papillomavirus infection.
    Ward BE; Burkett B; Petersen C; Nuckols ML; Brennan C; Birch LM; Crum CP
    Int J Gynecol Pathol; 1990; 9(4):297-305. PubMed ID: 2174025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Papanicolau smear chances to be diagnostic for cervical squamous intraepithelial lesions (SIL) with or without detectable HPV DNA at in situ hybridization analysis.
    Sopracordevole F; Cadorin L; Muffato G; De Benetti L; Parin A
    Eur J Gynaecol Oncol; 1993; 14(4):336-8. PubMed ID: 8393793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific identification of human papillomavirus type in cervical smears and paraffin sections by in situ hybridization with radioactive probes: a preliminary communication.
    Gupta J; Gendelman HE; Naghashfar Z; Gupta P; Rosenshein N; Sawada E; Woodruff JD; Shah K
    Int J Gynecol Pathol; 1985; 4(3):211-8. PubMed ID: 2997054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of human papillomaviruses in exfoliated cervicovaginal cells by in situ DNA hybridization analysis.
    Pao CC; Lai CH; Wu SY; Young KC; Chang PL; Soong YK
    J Clin Microbiol; 1989 Jan; 27(1):168-73. PubMed ID: 2536386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus detection in cervical cells by in situ hybridization with biotinylated probes.
    Chardonnet Y; Béjui-Thivolet F; Guérin-Reverchon I
    Cytopathology; 1992; 3(6):341-50. PubMed ID: 1336676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus (HPV) cervical lesions: results from 300 Italian women studied with DNA hybridization techniques and morphology.
    Nuzzo F; Tison V; Castagnoli A; Tiboni M; De Villiers EM
    Tumori; 1988 Dec; 74(6):745-9. PubMed ID: 2852866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus in cervical smears taken from women wearing an intrauterine contraceptive device.
    Czeglédy J; Gergely L; Batár I
    Arch Gynecol Obstet; 1989; 244(2):87-9. PubMed ID: 2540722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with various types of human papillomavirus: covariation and diagnostic relevance of cytological findings in Papanicolaou smears.
    Tanaka H; Chua KL; Lindh E; Hjerpe A
    Cytopathology; 1993; 4(5):273-83. PubMed ID: 8274665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of high-risk human papillomavirus 16 deoxyribonucleic acid testing with cytological entities in peri and postmenopausal women.
    Kashyap V; Hedau S
    J Cytol; 2013 Jul; 30(3):190-4. PubMed ID: 24130412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transitional (urothelial) cell metaplasia of the uterine cervix: morphological assessment of 31 cases.
    Egan AJ; Russell P
    Int J Gynecol Pathol; 1997 Apr; 16(2):89-98. PubMed ID: 9100060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesonephric remnants or hyperplasia can cause abnormal pap smears: a study of three cases.
    Welsh T; Fu YS; Chan J; Brundage HA; Rutgers JL
    Int J Gynecol Pathol; 2003 Apr; 22(2):121-6. PubMed ID: 12649665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between Oxidative Stress and Physical Activity in Women with Squamous Intraepithelial Lesions in a Cervical Cancer Control Program in the Brazilian Amazon.
    Carneiro SR; da Silva Lima AA; de Fátima Silva Santos G; de Oliveira CSB; Almeida MCV; da Conceição Nascimento Pinheiro M
    Oxid Med Cell Longev; 2019; 2019():8909852. PubMed ID: 31737177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cervical Cytopathological Changes Associated with Onset of Menopause.
    Misra JS; Srivastava AN; Zaidi ZH
    J Midlife Health; 2018; 9(4):180-184. PubMed ID: 30692812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developing dashboards for performance improvement in cytopathology.
    Horback K; Sundling KE; Schmidt RJ; Cibas ES
    J Am Soc Cytopathol; 2021; 10(6):535-542. PubMed ID: 34362716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
    J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.